SCHEMBL3276190

SCHEMBL3276190

CN(c1ccccc1)C1CCCCC1O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 7/20 0.58
▸ ALDH1A1 P00352 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ PKM P14618 1/20 0.41
▸ KCNA5 P22460 1/20 0.39
▸ SIGMAR1 Q99720 2/20 0.39
▸ LTA4H P09960 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CYP2D6 P10635 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8961737 1.00 SLC18A3 (0.58) SLC18A3ALDH1A1LMNAMAPTHTT
SCHEMBL3277996 1.00 SLC18A3 (0.58) SLC18A3ALDH1A1LMNAMAPTHTT
SCHEMBL3277994 1.00 SLC18A3 (0.58) SLC18A3ALDH1A1LMNAMAPTHTT
SCHEMBL3276187 1.00 SLC18A3 (0.58) SLC18A3ALDH1A1LMNAMAPTHTT
SCHEMBL3276186 1.00 SLC18A3 (0.58) SLC18A3ALDH1A1LMNAMAPTHTT
SCHEMBL10993404 0.79 AKR1C3 (0.48) SLC18A3ALDH1A1KDM4ETSHR
SCHEMBL10815432 0.78 AKR1C3 (0.47) SLC18A3ALDH1A1KDM4ETSHR
SCHEMBL10815690 0.76 AKR1C3 (0.48) SLC18A3ALDH1A1KDM4ETSHR
SCHEMBL11693073 0.74 ALDH1A1 (0.47) ALDH1A1LMNAMAPTHTTPKM
SCHEMBL6391373 0.74 SLC18A3 (1.00) SLC18A3ALDH1A1KCNA5SIGMAR1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187468-B2 Preparation and use of chiral zeolites for liquid chromatography UNIVERSITY OF TEXAS AT EL PASO (US) 2012-05-29 — — US claimed
US-20100089831-A1 PREPARATION AND USE OF CHIRAL ZEOLITES FOR LIQUID CHROMATOGRAPHY UNIVERSITY OF TEXAS AT EI PASO 2010-04-15 — — US claimed
US-12042788-B2 Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis THE UNIVERSITY OF CHICAGO (US) 2024-07-23 — — US disclosed
US-20210053042-A1 STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS NATIONAL SCIENCE FOUNDATION 2021-02-25 — — US disclosed
US-20210053042-A1 STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS NATIONAL SCIENCE FOUNDATION 2021-02-25 — — US disclosed
US-8187468-B2 Preparation and use of chiral zeolites for liquid chromatography UNIVERSITY OF TEXAS AT EL PASO (US) 2012-05-29 — — US disclosed
US-20100089831-A1 PREPARATION AND USE OF CHIRAL ZEOLITES FOR LIQUID CHROMATOGRAPHY UNIVERSITY OF TEXAS AT EI PASO 2010-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12042788-B2 Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis CD69, TECR, MCM4 SLC18A3 2121/4885ALDH1A1 270/4885LMNA 3755/4885
US-20100089831-A1 PREPARATION AND USE OF CHIRAL ZEOLITES FOR LIQUID CHROMATOGRAPHY SLC39A11, SLC39A3, SLC39A14 SLC18A3 2937/4885ALDH1A1 4660/4885LMNA 186/4885
US-20210053042-A1 STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS CD69, TECR, MCM4 SLC18A3 2121/4885ALDH1A1 270/4885LMNA 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback